Skip to content

Outcome of ultrasound guided platelet rich plasma injection in partial thickness rotator cuff tear

OUTCOME OF ULTRASOUND GUIDED PLATELET RICH PLASMA INJECTION IN PARTIAL THICKNESS ROTATOR CUFF TEAR

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050314
Enrollment
30
Registered
2023-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M751- Rotator cuff tear or rupture, notspecified as traumatic

Interventions

Intervention1: Ultrasound guided platelet rich plasma injection: Partial thickness rotator cuff tear patients diagnosed clinically and on ultrasonography and patient who did not responds to conservati

Sponsors

Vardhman Mahavir Medical College and Safdurjung Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Partial thickness rotator cuff tear patients diagnosed clinically and on ultrasonography with more than 18 years of age. 2. Patient who did not responds to conservative treatment of 1 month and longer period.

Exclusion criteria

Exclusion criteria: 1. Prior surgery to involved shoulder within prior twelve months. 2. Pre-existing upper extremity pain, inflammatory arthritis, carpal tunnel syndrome of involved side, cervical neuropathy. 3. History of steroid injection in shoulder within 6 weeks. 4. Active infection at injection site. 5. Bleeding disorders, platelet count less than 1,50,000. 6. On anticoagulation therapy, oral non-steroidal anti-inflammatory drugs in previous 7 days.

Design outcomes

Primary

MeasureTime frame
Outcome of PRP injection in partial thickness rotator cuff tear in relation to 1.Pain using VAS (Visual Analogue Scale) 2. Disability using Shoulder Pain And Disability Index (SPADI). 3. Ultrasound grading of rotator cuff tear. 4. Active ROM of shoulder using goniometer.Timepoint: 0 week, 4 week, 12 week.

Secondary

MeasureTime frame
Any local injection site complications.Timepoint: 0 week, 4 week, 12 week.

Countries

India

Contacts

Public ContactDr Mohammed Al Majid K

VMMC and Safdurjung Hospital

rkwadhwa79@gmail.com01126164887

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026